BioSpace News Archive

The American Cancer Society, a global organization leading the fight for a world without cancer, and the national convenience store retailer, EG America, are teaming up again to raise money for life-saving programs, research, and services that will help patients and families touched by this lethal disease.

Partnership between Shields Health Solutions and Sentara Healthcare brings patients more support services, increased number of specialty drugs and expanded insurance coverage

In tandem with its research and development partner, Lobo Genetics Inc. (“Lobo”), HaluGen has successfully developed a turn-key operation to build, order, ship, process and deliver its Psychedelics Genetic Test.

New centers will open in Southern California to support an urgent need for plasma donations used to develop therapies for people with a variety of rare diseases

Multisystem inflammatory syndrome in children (MIS-C) was first formally recognized in May 2020 as a post-infectious syndrome in children exposed to the SARS-CoV-2 coronavirus

In the latest (free) report from Reuters Events’ Healthcare global healthcare leaders provide insights into forces to re-imagine, re-create, and re-define the entire system in a way that improves patient outcomes and experiences.

Renew Biopharma Inc., a preclinical drug discovery company, today announced a licensing agreement with Hypercann Agrogenetics Inc. giving Hypercann rights to use Renew’s proprietary engineered enzymes to modify Cannabis plants for improved profiles of cannabinoids.

- The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [ 18 F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography

Chemesis International Inc. is pleased to announce that its common shares listed for trading on the Canadian Securities Exchange will commence trading in Canadian currency under the new trading symbol of CSI as of Thursday, February 25, 2021.

Fact.MR, a global research & consulting firm, in their latest edition of the report, indicated that the laryngeal papillomatosis treatment market is likely to reflect exponential expansion in 2021 and beyond.